Apyx Medical appoints Wendy Levine to Board of Directors

Apyx Medical Corp

Wendy Levine appointed as a director effective August 25, 2021, expanding the Board to eight members.
Levine will serve on the Regulatory Compliance Committee.
She is Group President and head of advertising at 21GRAMS, part of Real Chemistry, with 25 years of healthcare marketing experience.
Previous roles include leadership at Johnson & Johnson, Novartis Vaccines, McCann Health, and GSW.
No arrangement with any other person led to her election; compensation follows standard director program.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Wendy Levine

Director

APYX · Apyx Medical Corp

Effective: 2021-08-25
Filed: August 30, 2021, 7:59 PM ET

On August 24, 2021, the Board of Direct ors (the “Board”) of Apyx Medical Corporation (the “Company”) appointed Wendy Levine to serve as a director of the Company, expanding its Board to eight (8) directors, effective August 25, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Wendy Levine was appointed as Director at Apyx Medical Corp.

Action: appointed
Role: Director

Exact text from the filing

On August 24, 2021, the Board of Direct ors (the “Board”) of Apyx Medical Corporation (the “Company”) appointed Wendy Levine to serve as a director of the Company, expanding its Board to eight (8) directors, effective August 25, 2021.

View on SEC.gov

Apyx Medical Corp filing history →

Source: SEC EDGAR

accession 0000719135-21-000068

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.